Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study). (Q44623891)
Jump to navigation
Jump to search
scientific article published on 24 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study). |
scientific article published on 24 April 2011 |
Statements
1 reference
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study). (English)
1 reference
Daniel Podzamczer
1 reference
B Clotet
1 reference
P Reiss
1 reference
J Andrade-Villanueva
1 reference
S Taylor
1 reference
J K Rockstroh
1 reference
P Domingo
1 reference
H J Gellermann
1 reference
L de Rossi
1 reference
V Cairns
1 reference
V Soriano
1 reference
24 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference